Advanced lab reagents market set for 11.8% growth through 2030

The global advanced lab reagents market is projected to grow from $1.67 billion in 2025 to $2.92 billion by 2030, driven by pharmaceutical and biotech research, molecular diagnostics and precision medicine. North America leads today, while Asia-Pacific is expected to be the fastest-growing region.

Why it matters: - Advanced lab reagents are central to drug discovery, diagnostics and translational research. - The market’s growth signals rising demand for more precise, reproducible and high-throughput lab tools. - Expanding use in chronic disease monitoring and biomarker testing ties the market directly to healthcare demand. - A free sample report and the full market report are available online.

What happened: - The Business Research Company said the advanced lab reagents market will grow from $1.67 billion in 2025 to $1.87 billion in 2026. - The report projects the market will reach $2.92 billion by 2030. - The forecast implies a 11.5% CAGR from 2025 to 2026 and 11.8% CAGR through 2030. - The report was published June 29, 2026, in London.

The details: - Advanced lab reagents include high-purity chemicals, buffers, enzymes, antibodies, culture media and assay reagents. - These products are used in biotechnology, pharmaceuticals, clinical diagnostics and academic research. - Growth drivers include rising R&D spending in pharmaceuticals and biotechnology. - The report also points to higher investment in academic and research institutions. - Increased incidence of chronic and infectious diseases is adding demand. - Adoption of molecular diagnostic technologies is supporting growth. - Demand for highly sensitive analytical testing is also expanding the market. - Looking ahead, the report cites precision medicine, automated laboratory workflows, cell and gene therapy research, biomarker-based diagnostics, advanced biologics and biosimilars as key demand drivers. - Emerging trends include high-purity, contamination-free reagents. - The report also flags growing demand for reproducible and standardized lab processes. - Multiplex and high-throughput assay reagents are gaining share. - Customized, application-specific reagent formulations are becoming more common. - Integration into clinical diagnostics and translational research is broadening use cases.

Between the lines: - The market’s growth is being pulled by both research and clinical applications, which broadens its customer base. - The emphasis on standardization and contamination control suggests labs are prioritizing reliability as test volumes rise. - The report’s focus on automation and high-throughput workflows points to continued pressure for faster, more scalable lab operations. - The CDC said in February 2024 that the share of people in the U.S. living with multiple chronic conditions rose from 42% in 2024 to 51% in 2025. - That trend supports stronger demand for diagnostic reagents in screening and long-term disease management. - North America held the largest market share in 2025 because of established healthcare infrastructure and high research investment. - Asia-Pacific is expected to be the fastest-growing region as research activity, healthcare expansion and diagnostic demand increase.

What's next: - The market is expected to keep expanding through 2030 as precision medicine and advanced diagnostics scale up. - Growth in cell and gene therapies, biologics and biosimilars should support longer-term reagent demand. - The report’s 2026 edition adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspot infographics and updated trend analysis. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America and the Middle East and Africa.